AKBA - Akebia Therapeutics, Inc.
1.25
0.030 2.400%
Share volume: 1,916,150
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.22
0.03
0.02%
Summary score
45%
Profitability
44%
Dept financing
41%
Liquidity
75%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-3.25%
Return on sales
-18.69%
Return on invested capital
0%
Total debt ratio
175.06%
Debt ratio change over timeo
-0.84%
Current Ratio
1.49%
Quick Ratio
1.28%
Cash Position Ratio
0.63%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
1.61%
Return on sales
9.71%
Return on invested capital
0%
Total debt ratio
90.88%
Debt ratio change over timeo
0%
Current Ratio
1.92%
Quick Ratio
1.78%
Cash Position Ratio
1.2%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-1.7%
Return on sales
-14.84%
Return on invested capital
0%
Total debt ratio
91.34%
Debt ratio change over time
0%
Current Ratio
1.55%
Quick Ratio
1.46%
Cash Position Ratio
1.13%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-100.46%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
-84.05%
Debt ratio change over time
-0.84%
Current Ratio
-0.95%
Quick Ratio
-0.96%
Cash Position Ratio
-1%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AKBA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -3.25% | 4.74% | 3.19% | 1.73% |
| Return on sales | -18.69% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 175.06% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -0.84% | -20.57% | -85.61% | 17.33% |
| Dept financing | 25% | 11% | 8% | 38% |
| Current Ratio | 1.92% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 1.78% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.2% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 45% | 57% | 38% |
| Short-term ratios | AKBA | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 1.61% | 6.06% | 4.18% | 1.7% |
| Return on sales | 9.71% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 63% | 50% | 34% | 23% |
| Total debt ratio | 90.88% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 48% | 20% | 15% | 25% |
| Current Ratio | 1.92% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 1.78% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.2% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 38% | 35% | 21% |